What poly-L-lactic acid is
Poly-L-lactic acid (PLLA) is a biodegradable, biocompatible polymer from the alpha-hydroxy acid family. It belongs to the same family of materials as absorbable sutures, with decades of documented surgical use before it reached aesthetic medicine. That fact helps when explaining the material's safety to the patient: the body recognizes it and metabolizes it.
In aesthetics, PLLA is used as microparticles which, once placed in the dermis, act as a stimulus for the tissue to produce new collagen. It is a biostimulator, not a filler: it adds no volume by itself.
Three ideas sum up its behavior:
- Same family as absorbable sutures.
- It breaks down completely into carbon dioxide and water; no residual material remains.
- It is not a filler: it prompts the tissue to build its own support.
How it builds collagen, step by step
PLLA's mechanism can be described in five stages:
- Deposit. The microparticles settle in the dermis.
- Response. A controlled subclinical inflammatory response develops around the particles.
- Activation. Macrophages encapsulate the particles and activate fibroblasts.
- Synthesis. Fibroblasts synthesize new type I collagen.
- Remodeling. The polymer breaks down and the collagen remains.
That is why the result does not deflate as can happen with a filler that is reabsorbed: what remains at the end is not product, it is the patient's own tissue. And that is also why it is a treatment that keeps improving after the sessions end.
The limit of conventional PLLA
Conventional PLLA deposits a substrate and waits for the cell to react. The quality of that reaction depends on each patient: their age, the condition of their skin, their inflammatory response. It is real stimulation, but without direction, which explains part of the variability in results between patients.
PLLA with exosomes: stimulation with direction
The fourth generation of biostimulation adds the missing layer: the signal. In Exosome + PLLA, the biomimetic exosome carries the message that tells the fibroblast what to build, how much and in what order, while PLLA provides the substrate. The aim is more orderly, predictable and physiological neocollagenesis instead of a simple inflammatory reaction.
The formula combines four actives:
- Biomimetic exosomes: cell-to-cell communication, tissue repair and regenerative processes.
- Poly-L-lactic acid: gradual fibroblast response and type I collagen synthesis.
- Reduced glutathione: an antioxidant that improves radiance and evenness of tone.
- Hyaluronic acid with carboxymethylcellulose (CMC): deep hydration and an optimal microenvironment for regeneration.
This allows two goals in one procedure: while the dermis gains density and firmness, the skin gains radiance.
Presentation and reconstitution
Exosome + PLLA comes in a box of 6 vials: 3 of 20 mg freeze-dried powder and 3 of 5 ml diluent, equivalent to 3 complete sessions —a full cycle with zero waste.
- Freeze-dried appearance: white porous solid.
- Reconstituted product: homogeneous milky-white suspension.
- Reconstitution: under strictly aseptic conditions, adding the diluent to the vial and mixing gently until a homogeneous suspension forms; avoid excessive shaking.
- Storage: before reconstitution, in a cool, dry place protected from light; once reconstituted, between 2 °C and 8 °C and use within 7 days.
- Shelf life: 24 months.
Protocol and techniques
| Phase | Schedule |
|---|---|
| Start | 1 session every 4 weeks (induction phase) |
| Cycle | 3 sessions = 1 box |
| Maintenance | Every 3 to 6 months, per assessment |
Application techniques: advanced facial mesotherapy, cannula infiltration, professional microneedling, dermapen and intradermal micro-injection. It should only be applied with the technique and depth for which the practitioner holds certified training, and never intravascularly.
Treatment areas (8): face, neck, décolleté, hands, arms, abdomen, buttocks and legs.
When results show
| When | What happens |
|---|---|
| Weeks 1–2 | Immediate radiance and hydration: hyaluronic acid and glutathione act first |
| Weeks 4–6 | More even texture and finer pores: the matrix starts to reorganize |
| Weeks 8–12 | Real firmness and density: neocollagenesis becomes evident |
| Months 4–6 | Rejuvenation that matures: collagen keeps remodeling; ideal time for maintenance |
Indications
- Comprehensive facial rejuvenation.
- Mild to moderate laxity.
- Loss of dermal density and tissue support.
- Photoaging.
- Enlarged pores and uneven texture.
- Devitalized skin.
- Body application: arms, abdomen, buttocks and legs.
Pros and cons of poly-L-lactic acid
Pros
- Natural result: it does not change the patient's features.
- The patient's own tissue: the result does not depend on the product remaining.
- Progressive, long-lasting effect that keeps maturing for months.
- A well-known material from the absorbable-suture family that breaks down completely.
- Versatility: face and body with the same inventory.
Cons
- It is not immediate: it takes patience and several sessions.
- It depends on technique: reconstitution and application must be correct.
- Possible temporary, self-limiting inflammatory nodules, as well as erythema or mild edema.
- Variable response between patients with conventional PLLA, which the combination with exosomes aims to reduce.
How to reduce the risk of nodules
Nodules are the most discussed complication of particle-based biostimulators. Much of the risk depends on technique, so it pays to take care over these points:
- Correct reconstitution: use the stated volume of diluent and mix until the suspension is homogeneous, with no visible clumps.
- Right plane and depth: place the product in the plane indicated by the manufacturer and for which you are trained; avoid overly superficial deposits in thin-skinned areas.
- Even distribution: spread the product across the whole area instead of concentrating it in spots.
- Avoid overcorrection: the result is built session by session; trying to achieve the final effect in one session raises the risk.
- High-movement areas: take particular care around the eyes and mouth.
- Follow the manufacturer's aftercare during the first 48 hours.
If a nodule appears, the practitioner's assessment will determine the most appropriate management.
Who is a good candidate and who is not
Good candidate: a patient with mild to moderate laxity, loss of density or devitalized skin who wants a natural result, understands that improvement is progressive and is willing to complete the cycle and maintenance.
Less suitable candidate: a patient expecting an immediate change for an upcoming event, with severe laxity that calls for another approach, with inflamed or barrier-compromised skin —which is better repaired first— or with any of the product's contraindications.
How it combines with other treatments
| If the patient already uses… | What PLLA with exosomes adds |
|---|---|
| Hyaluronic acid skin booster | Structure, not just water |
| Botulinum toxin | It improves the dermis over the relaxed muscle; they enhance each other |
| Thread lifts | Density that supports and extends the thread result |
| Nothing regenerative | An entry point with a progressive result |
In skin with a compromised barrier, it is better to repair first with Exosome + GHK-Cu and biostimulate afterwards, as described in the combined protocol.
Aftercare and contraindications
During the first 48 hours it is advisable to avoid intense sun exposure, excessive heat, saunas and vigorous massage. Tell the patient that temporary erythema, mild edema or self-limiting inflammatory nodules may appear.
Contraindicated in: hypersensitivity to any component, pregnancy and breastfeeding, minors, active infection in the area, acute inflammatory processes, open wounds, active autoimmune disease, coagulation disorders, uncontrolled diabetes mellitus and a tendency to form keloids.
Setting expectations at the first visit
The most useful message for a PLLA patient is about time: "You will see freshness in the first weeks, real firmness from the second or third month, and the result will keep improving after we finish." Patients who hear this at the start are far less likely to judge the treatment too early or abandon the cycle.
Summary
Poly-L-lactic acid is a biodegradable biostimulator that teaches the skin to produce its own type I collagen. Its result is natural, progressive and long-lasting, but it requires patience, technique and several sessions. Combined with exosomes, the stimulus gains direction, and with glutathione and hyaluronic acid the treatment adds radiance and hydration from the first weeks.
See the profile of Exosome + PLLA, compare it with other types in collagen biostimulators or buy it from our authorized distributors.
Informational content for healthcare professionals. It does not replace individual clinical assessment or the manufacturer's instructions.
Frequently asked questions
What is poly-L-lactic acid?
It is a biodegradable polymer from the alpha-hydroxy acid family, the same family as absorbable sutures. In aesthetic medicine it is used as a biostimulator: it induces production of the patient's own collagen and then breaks down completely.
What is poly-L-lactic acid used for?
To improve firmness, dermal density and tissue support in mild to moderate laxity, loss of density, photoaging, uneven texture and enlarged pores, on both face and body.
When do poly-L-lactic acid results show?
Improvement is gradual. With Exosome + PLLA, radiance and hydration show in weeks 1 and 2; firmness and density between weeks 8 and 12; and the result keeps maturing between months 4 and 6.
Is poly-L-lactic acid a filler?
No. It adds no volume by itself; it prompts the tissue to generate its own collagen. That is why the result does not deflate: what remains at the end is the patient's own tissue.
What are the disadvantages of poly-L-lactic acid?
Its effect is not immediate, it requires several sessions and correct reconstitution and application technique, and it can cause temporary inflammatory nodules. Careful patient selection and following the manufacturer's instructions are essential.
